In vitro-in vivo antifungal evaluation and structure-activity relationships of 3H-1,2-dithiole-3-thione derivatives

Farmaco

Volumn 59, Issue 4, 2004, Pages 245-254

  Giannini, Fernando A ^a   Aimar, Mario L ^b   Sortino, Maximiliano ^c   Gomez, Roxana ^a   Sturniollo, Alejandro ^a   Juarez, Americo ^a   Zacchino, Susana ^c   De Rossi, Rita H ^b   Enriz, Ricardo D ^a  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

3H 1,2 dithiole 3 thione; Antifungal activity; In vitro in vivo activity

Indexed keywords

1,2 DITHIOLE 3 THIONE DERIVATIVE; 4 CHLORO 5 ETHYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 4 METHOXY 5 ETHYLDITHIO 3H 1,2 DITHIOLE 3 THIONE; 4 METHOXY 5 ETHYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 4 METHYL 5 ETHYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 4 PHENYL 5 ETHYLDITHIO 3H 1,2 DITHIOLE 3 THIONE; 4 PHENYL 5 ETHYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 BENZYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 BUTYL 3H 1,2 DITHIOLE 3 THIONE; 5 CYCLOPENTYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 DECYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 DODECYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 HEXYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 OCTYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 PHENYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 PROPYLTHIO 3H 1,2 DITHIOLE 3 THIONE; 5 TERT BUTYLTHIO 3H 1,2 DITHIOLE 3 THIONE; ETHYLTHIO 3H 1,2 DITHIOLE 3 THIONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; FUNGUS; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIFUNGAL AGENTS; GUINEA PIGS; HUMANS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; THIONES; THIOPHENES; TINEA; TRITIUM;

EID: 1842714465     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2003.08.004     Document Type: Article

References (24)

1. Barret Bee K.J., Ryder N.S. Biochemical aspects of ergosterol biosynthesis inhibition. Sutcliffe J.M., Georgopapadakou N.H. Emerging Targets in Antibacterial and Antifungal Chemoterapy. 1992;410-436 Chapman and Hall, New York.
2. Fromtling R.A. Human mycoses and current antifungal therapy. Drugs News Perspect. 11:1998;185-191.
3. Walsh T. Invasive fungal infections: problems and challenges for developing new antifungal compounds. Sutcliffe J., Georgopapadakou N.H. Emerging Targets in Antibacterial and Antifungal Chemotherapy. 1992;349-373 Chapman and Hall, New York.
4. Cáceres A., Lopez B.R., Giron M.A., Logeman H.J. Plants used in Guatemala forthe treatment of dermatophytic infections. 1. Screening for antimycotic activity of 44 plant extracts. J. Ethnopharmacol. 31:1991;263-276.
5. White T.C., Marr K.A., Bowdenn R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:1998;382-390.
6. Fromtling R.A. Progress in antifungal chemoterapy. Drug New Perspect. 12:1999;557-569.
7. Ablordeppey S.Y., Fan P., Ablordeppey J.M., Mardenborough L. Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development. Curr. Med. Chem. 6:1999;1115-1195.
8. Zacchino S., Rodriguez G., Pezzenati G., Orellana G., Enriz R.D., Gonzalez Sierra M. In vitro evaluation of antifungal properties of neolignans-8.O.4′ J. Nat. Prod. 60:1997;660-662.
9. Zacchino S., López S., Pezzenati G., Furlán R., Santecchia C., Muñoz L., et al. In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes. J. Nat. Prod. 62:1999;1353-1357.
10. Zacchino S., Rodríguez G., Santecchia C., Pezzenati G., Giannini F., Enriz R.D. In vitro studies on mode of action of antifungal neolignans occurring in certain species of Virola and related genera of Myristicaceae. J. Ethnopharmacol. 62:1998;35-41.
11. López S., Castelli M., Zacchino S., Dominguez J., Lobo G., Charris-Charris J.G., et al. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg. Med. Chem. 9:1999;2.001-2.013.
12. Urbina J.M., Cortés J.C., Palma A., López S., Zacchino S., Enriz R.D., et al. Inhibitors of the fungal wall, synthesis of 4-aryl-4-N-arylamino-1-butenes and related compounds with inhibitory activities of glucan and chitin synthases. Bioorgn. Med. Chem. 8:2000;691-698.
13. Vargas L.Y., Castelli M., Kouznetsov V., Urbina J.M., Lopez S.N., Sortino M.R.D., et al. Synthesis, in-vitro antifungal evaluation and structure activity relationship of a new series of homoalylamines and related compounds with inhibitory properties of polymers of the fungal cell wall. Bioorgn. Med. Chem. 11:2003;1531-1550.
14. Zacchino S., Yunes R.A., Cechinel F., Filho V., Enriz R.D., Kouznetsov V., et al. The need of new antifungal drugs. Screening for antifungal compounds with a selective mode of action with emphasis in the inhibitors of the fungal cell wall. Rai M.K., Mares D. Plant-Detived Antimycotics. 2003;1-47 Haworth Press, New York.
15. Aimar M.L., de Rossi R.H. One pot synthesis of 5-alkylthio, 3H-1,2-dithiole-3-thiones. Tetrahedron Lett. 37:1996;2137-2148.
16. Aimar M.L., de Rossi R.H. One pot synthesis of 5-alkylthio-3H-1,2- dithiole-3-thiones: advantages and scopes. Synthesis. 12:2000;1749-1754.
17. Aimar M.L., Kreiker J., de Rossi R.H. One pot synthesis of 3H-1,2-dithiole-3-thiones derivatives from dithiolmalonic esters. Tetrahedron Lett. 43:2002;1947-1956.
18. Wright L., Scott E., Gorman S. The sensitive of mycelium, arthrospores and microconidia of Trichophyton mentagrophytes to imidazoles determined by in vitro tests. J. Antimicrob. Chemother. 12:1983;317-323.
19. Rippon J.W. Animal models of experimental dermatophytic infections. Zac O., Merle A.S. Experimental Models in Animals Experiments. vol. 3:1986;Academic Press, London.
20. Ryley J.F. Screening and evaluation in vivo. Ryley J.F. Chemotherapy of Fungal Diseases. 1990;129-148 Springer, Berlin.
21. Polak A. Oxiconazole, a new imidazol derivative. Drug Res. 32:1982;17-24.
22. Károlyházy L., Freile M., Anwair M.N.S., Beke G., Giannini F., Castelli M.V., et al. Synthesis, in vitro/in vivo antifungal evaluation and structure-activity relationship study of 3(2H)-Pyridazinones. Drug Res. 53:2003;738-743.
23. Freile M.L., Giannini F.A., Pucci G., Sturniolo A., Roidero L., Pucci O., et al. In vivo antifungal activity and toxicity of berberine isolated from. Berberis heterophylla, Filoterapia. 74:2003;702-705.
24. Alchemy32 Version 2.0 Copyright 1997, Tripos, Inc. St Louis, MO (USA).